IntoCell and Xcellon Biologics Partner to Advance Next-Generation ADC Development and Manufacturing Read more
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ First-in-Class Gastric Cancer Drug Read more
Seres Therapeutics Receives $3.6 Million CARB-X Grant to Develop Liquid Form of SER-155 for Infection Prevention Read more
FDA Moves to Streamline Biosimilar Development, Cut Costs and Speed Access to Affordable Biologic Alternatives Read more
AI in Drug Discovery 2026: Novo Nordisk’s Peter Clark to Chair Landmark Event Driving AI Integration in Pharma Read more